Published in Lancet on July 25, 1981
Inappropriate comparisons of incidence and prevalence in epidemiologic research. Am J Public Health (1989) 0.94
Influence of acid rain upon water plumbosolvency. Environ Health Perspect (1985) 0.77
Decline of maternal blood lead concentrations in Glasgow. J Epidemiol Community Health (1998) 0.75
A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J Bone Joint Surg Br (2003) 4.16
Blood-lead and hypertension. Lancet (1976) 2.82
Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant (2012) 2.46
Environmental lead pollution in an urban soft-water area. Br Med J (1972) 2.28
The diagnosis of industrial lead poisoning. Br J Ind Med (1968) 2.23
Do pregnant women take their iron? Lancet (1969) 2.10
Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc Natl Acad Sci U S A (1997) 2.08
Lead poisoning in rural Scotland. Br Med J (1972) 2.08
Summaries and selective destruction as a solution to the hospital record storage problem. Lancet (1967) 2.05
Choleic acids. Biochem J (1932) 2.02
Lead and delta-aminolaevulinic acid dehydratase levels in mentally retarded children and in lead-poisoned suckling rats. Lancet (1970) 1.93
Hereditary coproporphyria. Demonstration of the abnormalities in haem biosynthesis in peripheral blood. Q J Med (1977) 1.91
Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther (2012) 1.89
Neonatal rickets in Asian immigrant population. Br Med J (1973) 1.87
Diagnosis of upper gastro-intestinal bleeding. Br Med J (1965) 1.84
Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes. Am J Transplant (2013) 1.77
Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria. Gastroenterology (1993) 1.76
Controlled trial of haem arginate in acute hepatic porphyria. Lancet (1989) 1.75
Low level exposure to lead. BMJ (1990) 1.67
Skin test results and self-reported symptom severity in allergic rhinitis: The role of psychological factors. Clin Exp Allergy (2006) 1.59
The drug disc. Warning system for drug interactions. Lancet (1973) 1.56
An assessment of digoxin radio-immunoassay. Scott Med J (1973) 1.55
Unified nomenclature for subunits of the Saccharomyces cerevisiae proteasome regulatory particle. Trends Biochem Sci (1998) 1.55
Debilitating beliefs, emotional distress and quality of life in patients given immunotherapy for insect sting allergy. Clin Exp Allergy (1999) 1.52
Life satisfaction and quality in Korean War veterans five decades after the war. J Epidemiol Community Health (2009) 1.48
Magnesium binding by Escherichia coli ribosomes. J Mol Biol (1966) 1.46
Depression of delta-aminolaevulic acid dehydrase activity by ethanol in man and rat. Clin Sci (1971) 1.45
A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group. Neurology (1996) 1.45
Re-assessment of risk factors for sporadic Salmonella serotype Enteritidis infections: a case-control study in five FoodNet Sites, 2002-2003. Epidemiol Infect (2006) 1.43
Blood lead levels in normal and mentally deficiency children. Arch Dis Child (1967) 1.41
Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension. Am J Cardiol (2001) 1.41
Ascorbic-acid levels in leucocytes of patients with gastrointestinal haemorrhage. Lancet (1968) 1.40
Writing case histories. Int J Psychoanal (1997) 1.39
Role of chronic low-level lead exposure in the aetiology of mental retardation. Lancet (1975) 1.39
Between empathy and judgment. J Am Psychoanal Assoc (1999) 1.38
Medics in the Israel Defense Forces and their experience in trauma care during peacetime. Isr Med Assoc J (1999) 1.38
Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation (1995) 1.36
Acute intermittent porphyria: response of tachycardia and hypertension to propranolol. Br Med J (1973) 1.35
Treatment with haematin in acute hepatic porphyria. Q J Med (1981) 1.29
Renal insufficiency associated with excessive lead exposure. Br Med J (1977) 1.29
Strength training increases resting metabolic rate and norepinephrine levels in healthy 50- to 65-yr-old men. J Appl Physiol (1985) (1994) 1.29
Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol Sci (1999) 1.23
The neurotoxicology of lead. Neurotoxicology (1986) 1.22
Lead poisoning as a disorder of heme synthesis. Semin Hematol (1968) 1.22
Computer-assisted interactive three-dimensional planning for neurosurgical procedures. Neurosurgery (1996) 1.19
Drinking water as a source of lead pollution. Environ Health Perspect (1974) 1.19
Induction of delta-aminolaevulinic acid synthase in leucocytes of patients on phenytoin therapy--comparison with changes in rat hepatic tissue. Br J Clin Pharmacol (1980) 1.19
Tetraethyl-lead poisoning. Lancet (1972) 1.18
Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities. J Med Genet (1982) 1.15
[Contribution of lead in drinking water to blood-lead]. Lancet (1977) 1.15
MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients. Cancer (1973) 1.14
Heme biosynthesis in Friend erythroleukemia cells: control by ferrochelatase. Proc Natl Acad Sci U S A (1979) 1.14
Food iron and lead absorption in humans. Am J Clin Nutr (1986) 1.13
Effect of certain anaesthetic agents on the activity of rat hepatic delta-aminolaevulinate synthase. Br J Anaesth (1978) 1.13
Measurement of leucocyte ascorbic acid. Br Med J (1966) 1.12
Various Bacillus Typhosus Antigens Used for the Macroscopic Widal. Am J Public Health Nations Health (1935) 1.12
Lead poisoning and haem biosynthesis. Br J Haematol (1972) 1.11
Methylenetetrahydrofolate dehydrogenase from Clostridium formicoaceticum and methylenetetrahydrofolate dehydrogenase, methenyltetrahydrofolate cyclohydrolase (combined) from Clostridium thermoaceticum. Methods Enzymol (1980) 1.11
Hereditary coproporphyria. Lancet (1967) 1.11
Blood-lead and cadmium in human hypertension. J Environ Pathol Toxicol (1980) 1.09
Fusion of liposomes containing conductance probes with black lipid films. Biochim Biophys Acta (1976) 1.08
Safe levels of cadmium intake to prevent renal toxicity in human subjects. Br J Nutr (2000) 1.08
Androgenic control of the harderian gland in the male golden hamster. J Endocrinol (1977) 1.08
Autonomic neuropathy in acute intermittent porphyria. J Neurol Neurosurg Psychiatry (1985) 1.07
Is lead in tap water still a public health problem? An observational study in Glasgow. BMJ (1996) 1.07
Randomized comparison between low-pressure laparoscopic cholecystectomy and gasless laparoscopic cholecystectomy. Surg Endosc (1999) 1.07
Oral absorption of lead and iron. Lancet (1980) 1.06
mu-opioid receptors are present in vagal afferents and their dendritic targets in the medial nucleus tractus solitarius. J Comp Neurol (2000) 1.05
Purification and characterization of nicotinamide adenine dinucleotide-dependent methylenetetrahydrofolate dehydrogenase from Clostridium formicoaceticum. J Biol Chem (1974) 1.05
Rapid degradation of an abnormal protein in Escherichia coli proceeds through repeated cycles of association with GroEL. J Biol Chem (1999) 1.05
Refractory anemia with dysproteinemia: long-term therapy with low-dose corticosteroids. Blood (1973) 1.05
The effect of calcium on lead absorption in rats. Biochem J (1977) 1.05
Radiochromium in the selection of patients with haemolytic anaemia for splenectomy. Lancet (1966) 1.04
Successful abatement of lead exposure from water supplies in the West of Scotland. Environ Res (1985) 1.03
Effects of aluminium, lead and zinc on delta-aminolaevulinic acid dehydratase. Enzyme (1977) 1.03
Acute hepatic porphyrias. Clin Haematol (1980) 1.02
Detection of latent pernicious anaemia in iron-deficiency anaemia. Br Med J (1966) 1.02
Enzyme abnormalities in the porphyrias. Lancet (1977) 1.02
Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine. Cancer Res (1981) 1.02
Lead in water, infant diet and blood: the Glasgow Duplicate Diet Study. Sci Total Environ (1985) 1.01
Mast cells in the hamster Harderian gland: sex differences, hormonal control and relationship to porphyrin. J Anat (1982) 1.01
Experimental griseofulvin porphyria in adult and foetal mice. Br J Dermatol (1967) 1.01